换一批
换一批Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
第一作者：
Jeffrey T,Billheimer
第一单位：
Department of Chemical Enzymology, Bristol-Myers Squibb Pharma Company, Wilmington, DE 19880-0400, USA.
作者：
主题词
投药, 口服(Administration, Oral);脒类(Amidines);动物(Animals);抗体(Antibodies);生物利用度(Biological Availability);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);表位(Epitopes);人类(Humans);异恶唑类(Isoxazoles);动力学(Kinetics);黑猩猩属(Pan troglodytes);血小板糖蛋白GPⅡb-Ⅲa复合物(Platelet Glycoprotein GPIIb-IIIa Complex);蛋白质构象(Protein Conformation);敏感性与特异性(Sensitivity and Specificity);血小板减少(Thrombocytopenia)
DOI
10.1182/blood.v99.10.3540
PMID
11986205
发布时间
2021-02-16
- 浏览18
Blood
3540-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
